Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Endocrinología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
ClinicalTrials.gov
An Observational Follow-Up Study Of Patients Previously Enrolled In Exubera Controlled Clinical Trials
OBSERVATIONAL
Inicio: 1 de ago de 2008
ID: NCT00734591
Terminado
Fase 3
ClinicalTrials.gov
A 52-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis
INTERVENTIONAL
Inicio: 1 de feb de 2018
ID: NCT03383146
Completado
Fase 3
ClinicalTrials.gov
a Phase 3 Randomized Double Blind Evaluation of LY353381 Compared With Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.
INTERVENTIONAL
ID: NCT00034125
Completado
Fase 3
ClinicalTrials.gov
A 78 Week Open Label Extension to Trials Assessing the Safety and Efficacy of BI 1356 (5 mg) as Monotherapy or in Combination With Other Antidiabetic Medications in Type 2 Diabetic Patients.
INTERVENTIONAL
Inicio: 1 de ago de 2008
ID: NCT00736099
Completado
Fase 3
ClinicalTrials.gov
An 8-Month Phase 3, Open-Label Study With a Blinded Reversal Phase to Evaluate the Safety and Tolerability of TAK-491 in Subjects With Essential Hypertension
INTERVENTIONAL
Inicio: 1 de jun de 2007
ID: NCT00696384
Completado
ClinicalTrials.gov
Multicentre NIS Retrospective Study to Know the Prevalence of HER2- Low,Clinical Characteristics,Treatment Patterns,Associated Outcome in Patient With HER2-negative in Metastatic Breast Cancer Who Progressed on Systemic Anticancer Therapy
OBSERVATIONAL
Inicio: 23 de abr de 2024
ID: NCT06131424
Aún no recluta
Fase 3
ClinicalTrials.gov
Efficacy and Safety of NNC0487-0111 s.c. Once-weekly Compared to Semaglutide s.c. Once-weekly in Participants With Overweight or Obesity, and Type 2 Diabetes (AMAZE 8)
INTERVENTIONAL
Inicio: 20 de may de 2026
ID: NCT07400107
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, 12-month Treatment, Multicenter, Randomized, Open-Label, Parallel Group Clinical Trial Comparing Prandial Subcutaneous Insulin With Prandial Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma
INTERVENTIONAL
Inicio: 1 de jun de 2006
ID: NCT00332826
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Retatrutide Compared to Tirzepatide in Adults Who Have Obesity
INTERVENTIONAL
Inicio: 1 de nov de 2024
ID: NCT06662383
Activo, no recluta
Fase 3
ClinicalTrials.gov
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
INTERVENTIONAL
Inicio: 14 de abr de 2022
ID: NCT05288166
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects With Type 2 Diabetes Mellitus and Diabetic Nephropathy
INTERVENTIONAL
Inicio: 17 de feb de 2014
ID: NCT02065791
Completado
Fase 3
ClinicalTrials.gov
A PHASE 3B STUDY TO EVALUATE THE POTENTIAL OF ALEGLITAZAR TO REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH STABLE CARDIOVASCULAR DISEASE AND GLUCOSE ABNORMALITIES
INTERVENTIONAL
Inicio: 1 de dic de 2012
ID: NCT01715818
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Double-blind, Parallel Group Study to Evaluate the Efficacy and Safety of Linagliptin 5 mg Compared to Placebo, Administered as Oral Fixed Dose Combination With Empagliflozin 10 mg or 25 mg for 24 Weeks, in Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control After 16 Weeks of Treatment With Empagliflozin 10 mg or 25 mg on Metformin Background Therapy
INTERVENTIONAL
Inicio: 1 de ene de 2013
ID: NCT01778049
Completado
Fase 3
ClinicalTrials.gov
A Trial Comparing the Effect and Safety of Insulin Degludec Versus Insulin Detemir, Both in Combination With Insulin Aspart, in the Treatment of Pregnant Women With Type 1 Diabetes
INTERVENTIONAL
Inicio: 22 de nov de 2017
ID: NCT03377699
Completado
Fase 4
ClinicalTrials.gov
A Multi-national, Open-labelled, Randomised, Parallel Group, 4 Week run-in and 26 Weeks Treat-to-target Comparison of Biphasic Insulin Aspart 30 Once Daily Versus Insulin Glargine Once Daily Both in Combination With Metformin and Glimepiride in Insulin naïve Subjects With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de may de 2007
ID: NCT00469092
Activo, no recluta
ClinicalTrials.gov
A Trial for a Procedure for Duodenum to Ileal Diversion to Treat Type 2 Diabetes
INTERVENTIONAL
Inicio: 23 de sept de 2019
ID: NCT03130244
Completado
Fase 4
ClinicalTrials.gov
An Open Label, Multi-center Pasireotide Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Pasireotide Study and Are Judged by the Investigator to Benefit From Continued Pasireotide Treatment
INTERVENTIONAL
Inicio: 10 de jun de 2013
ID: NCT01794793
Completado
Fase 3
ClinicalTrials.gov
A 52-Week International, Multi-centre, Randomised, Parallel-group, Double-blind, Active-controlled, Phase III Study With a 156-Week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin in Combination With Metformin Compared With Sulphonylurea in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Metformin Therapy Alone.
INTERVENTIONAL
Inicio: 1 de mar de 2008
ID: NCT00660907
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Trial to Evaluate the Efficacy and Safety of LY3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (QWINT-3)
INTERVENTIONAL
Inicio: 8 de mar de 2022
ID: NCT05275400
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Dose Ranging, Dose Comparison-Controlled Trial to Determine the Safety and Efficacy of BMS-298585 in Subjects With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de may de 2002
ID: NCT00240383
Anterior
1
...
33
34
35
...
434
Siguiente
Filtros